Press release
Cancer Tissue Diagnostics Market Poised for Significant Growth, Forecasted to Reach USD 11.9 Billion by 2031
Tissue diagnostics plays a crucial role in cancer diagnosis and treatment planning, offering highly accurate insights into the biological structure of cancer cells. The rising global burden of cancer and increasing demand for early diagnosis are major factors propelling the growth of the cancer tissue diagnostics market. According to recent estimates, The Cancer Tissue Diagnostics Market is projected to grow from USD 7.4 Bn in 2024 to USD 11.9 Bn by 2031, reflecting a CAGR of 7.0% during the forecast period, driven by the adoption of advanced diagnostic tools and digital pathology solutions.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/33842
The North American region dominates the market due to high cancer prevalence, strong healthcare infrastructure, and widespread awareness of early cancer detection. Meanwhile, the breast cancer segment leads the market, attributed to the increasing incidence of breast cancer worldwide and the necessity for effective diagnostic techniques.
Key Highlights from the Report
• The cancer tissue diagnostics market is expected to witness robust growth, driven by the rising global cancer burden.
• North America remains the leading region due to advancements in healthcare infrastructure and increasing cancer screening initiatives.
• Breast cancer represents the largest segment in the market, with growing research and screening programs fueling its expansion.
• The adoption of digital pathology and AI-based diagnostic solutions is transforming cancer tissue diagnostics.
• Key market players are investing in research and partnerships to develop next-generation cancer diagnostic solutions.
• Emerging markets in Asia-Pacific are showing rapid growth potential due to improved healthcare access and government initiatives promoting cancer screening.
Market Segmentation
The cancer tissue diagnostics market is segmented based on test type, product type, and end-user.
By Test Type
Histopathology tests dominate the market, with immunohistochemistry (IHC) and in-situ hybridization (ISH) emerging as key diagnostic techniques. These methods allow precise identification of cancer cell markers, aiding in personalized treatment strategies.
By Product Type
The market includes consumables such as reagents and antibodies, as well as instruments like slide scanners and staining systems. The consumables segment holds the largest share due to the frequent use of reagents in cancer diagnostics.
By End-User
Hospitals, diagnostic laboratories, and research institutions represent the primary end-users of cancer tissue diagnostics. Hospitals lead the segment due to high patient inflow and the availability of advanced diagnostic facilities.
Regional Insights
North America
North America remains the leading region due to high cancer prevalence, early adoption of advanced diagnostic tools, and significant investments in healthcare research. The American Cancer Society estimates that nearly 1.96 million new cancer cases were diagnosed in the U.S. in 2023, underscoring the region's increasing demand for precise diagnostic solutions.
Europe
Europe follows closely behind, with Germany, France, and the U.K. driving market growth. The rising aging population and government-led cancer screening programs support the demand for cancer tissue diagnostics in this region.
Asia-Pacific
Asia-Pacific is witnessing the fastest market expansion, with China, India, and Japan at the forefront. Improved healthcare infrastructure, growing awareness of cancer screening, and increased healthcare spending contribute to the region's rapid growth.
Market Drivers
The growing global cancer burden is a primary driver for market expansion. According to the World Health Organization, cancer cases are expected to rise significantly in the coming years, emphasizing the need for accurate diagnostic tools. Additionally, advancements in digital pathology, artificial intelligence, and biomarker-based diagnostics are revolutionizing cancer tissue diagnostics, enhancing accuracy and efficiency.
Market Restraints
One of the primary challenges facing the market is the shortage of skilled professionals in histopathology labs. Many laboratories struggle with understaffing, which hampers diagnostic efficiency. Additionally, the increasing adoption of refurbished diagnostic imaging systems in cost-sensitive regions limits the market growth of new diagnostic instruments.
Market Opportunities
The development of novel cancer biomarkers presents significant opportunities for market growth. Advancements in biotechnology are enabling the discovery of more precise cancer markers, facilitating early detection and personalized treatment strategies. Additionally, the expansion of healthcare facilities in emerging economies offers a lucrative opportunity for market players.
Reasons to Buy the Report
✔ Comprehensive insights into market trends, key drivers, and challenges.
✔ Detailed segmentation analysis, helping stakeholders understand market dynamics.
✔ Regional analysis highlighting growth potential in key markets.
✔ Insights into competitive strategies and key developments by major players. ✔ Forecasts and future outlook to guide investment decisions.
Frequently Asked Questions (FAQs)
How big is the cancer tissue diagnostics market?
Who are the key players in the global cancer tissue diagnostics market?
What is the projected growth rate of the market?
What is the market forecast for 2031?
Which region is estimated to dominate the industry through the forecast period?
Company Insights
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific Inc.
Abbott Laboratories
Bio-Rad Laboratories Inc.
Ventana Medical Systems, Inc.
Recent Developments
Roche launched a new AI-powered digital pathology solution to enhance cancer diagnostics.
Thermo Fisher Scientific introduced an advanced biomarker-based tissue diagnostics platform to improve cancer detection and treatment planning.
Conclusion
The cancer tissue diagnostics market is poised for significant growth, driven by the rising incidence of cancer and advancements in diagnostic technologies. North America continues to lead the market, while emerging economies in Asia-Pacific present promising opportunities for expansion. Innovations in digital pathology, biomarker-based diagnostics, and AI-driven diagnostic tools are set to redefine the future of cancer diagnostics. Despite challenges such as workforce shortages and the adoption of refurbished equipment, the market remains highly dynamic, with key players investing in research and development to enhance diagnostic accuracy and accessibility. As early detection and precision medicine become integral to cancer treatment, the demand for advanced cancer tissue diagnostics will continue to rise, shaping the future of oncology diagnostics.
Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web:
https://www.persistencemarketresearch.com
About Persistence Market Research:
At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.
Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Tissue Diagnostics Market Poised for Significant Growth, Forecasted to Reach USD 11.9 Billion by 2031 here
News-ID: 3930842 • Views: …
More Releases from Persistence Market Research
Packaging Machinery Market to Surpass US$ 82.3 Bn by 2030 with Steady 4.7% CAGR …
➤Overview of the Market
According to the latest analysis by Persistence Market Research, the global packaging machinery market is projected to grow from US$ 59,737.4 million in 2023 to US$ 82,389.7 million by 2030, registering a CAGR of 4.7% during the forecast period. Rising consumer demand for packaged goods, automation, and technological upgrades in manufacturing are among the key forces transforming the industry landscape.
The packaging machinery market plays a vital role…
Packaging Tensioner Market Set to Reach US$ 13.3 Bn by 2030 with 3.8% CAGR - Per …
➤ Overview of the Market
According to Persistence Market Research, the global packaging tensioner market is projected to rise from US$ 10,237.5 million in 2023 to US$ 13,291.5 million by 2030, expanding at a CAGR of 3.8%. Packaging tensioners, essential for securing strapping around pallets, cartons, and bundled goods, are increasingly adopted across industries to ensure safe and efficient handling during transport. Growth is primarily driven by automation trends in packaging,…
Beverage Packaging Market to Surpass US$ 138.9 Bn by 2031 Driven by Sustainabili …
➤Overview of the Market
According to the latest study by Persistence Market Research, the global beverage packaging market is projected to grow at a CAGR of 4.1% from US$ 1,04,820.0 million in 2024 to US$ 1,38,867.1 million by 2031. Rising consumer preference for sustainable packaging, growing consumption of ready-to-drink products, and ongoing innovation in material science are major factors boosting the industry worldwide.
The beverage packaging industry plays a vital role in…
Actuators Device Market to Reach US$ 102.8 Bn by 2031 Fueled by 7% CAGR and Auto …
➤ Overview of the Market
The global actuators device market is poised for robust growth, projected to rise from US$ 67.7 Bn in 2024 to US$ 102.8 Bn by 2031 at a CAGR of 7%, according to Persistence Market Research. Rapid automation across industries, growing investment in industrial robotics, and expanding applications in aerospace, automotive, and medical devices are key catalysts for market acceleration.
The actuators device market encompasses mechanical systems that…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
